PT87456A - Diarylalkyl-substituierte alkylamine verfahren zu ihrer herstellung ihre verwendung sowie sie enthaltende arzneimittel - Google Patents

Diarylalkyl-substituierte alkylamine verfahren zu ihrer herstellung ihre verwendung sowie sie enthaltende arzneimittel

Info

Publication number
PT87456A
PT87456A PT87456A PT8745688A PT87456A PT 87456 A PT87456 A PT 87456A PT 87456 A PT87456 A PT 87456A PT 8745688 A PT8745688 A PT 8745688A PT 87456 A PT87456 A PT 87456A
Authority
PT
Portugal
Prior art keywords
diarylalkyl
verfahren
sie
sowie
alkylamine
Prior art date
Application number
PT87456A
Other languages
English (en)
Other versions
PT87456B (pt
Inventor
Wolfgang Rueger
Hausjoerg Urbach
Joachim Kaiser
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PT87456A publication Critical patent/PT87456A/pt
Publication of PT87456B publication Critical patent/PT87456B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Paints Or Removers (AREA)
PT87456A 1987-05-12 1988-05-11 Processo para a preparacao de alquilaminas substituidas por diarilalquilo e de composicoes farmaceuticas que as contem PT87456B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873715763 DE3715763A1 (de) 1987-05-12 1987-05-12 Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
PT87456A true PT87456A (pt) 1989-05-31
PT87456B PT87456B (pt) 1992-09-30

Family

ID=6327331

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87456A PT87456B (pt) 1987-05-12 1988-05-11 Processo para a preparacao de alquilaminas substituidas por diarilalquilo e de composicoes farmaceuticas que as contem

Country Status (14)

Country Link
US (1) US4933346A (pt)
EP (1) EP0290958A3 (pt)
JP (1) JPS63297358A (pt)
KR (1) KR880013893A (pt)
CN (1) CN88102650A (pt)
AU (1) AU1605588A (pt)
DE (1) DE3715763A1 (pt)
DK (1) DK259088A (pt)
FI (1) FI882177A (pt)
HU (1) HUT46897A (pt)
IL (1) IL86361A0 (pt)
NO (1) NO882065L (pt)
PT (1) PT87456B (pt)
ZA (1) ZA883342B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686438B2 (ja) * 1989-03-27 1994-11-02 三菱化成株式会社 アミノベンゼンスルホン酸誘導体
GB9113031D0 (en) * 1991-06-17 1991-08-07 Smithkline Beecham Plc Compounds
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
CA2422055A1 (en) 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053301A (pt) * 1963-01-14
GB1533383A (en) * 1974-11-15 1978-11-22 Science Union & Cie Arylethers and heterocyclic ethers processes for their preparation and pharmaceutical compositions containing them
GB1546238A (en) * 1976-04-07 1979-05-23 Serdex Soc D Etudes De Rech De Piperazine derivatives a process for their preparation and their applications
CH643549A5 (de) * 1979-08-25 1984-06-15 Merz & Co N-(trimethoxybenzyl)-n'-phenylpiperazine.
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
DE3529994A1 (de) * 1985-08-22 1987-02-26 Hoechst Ag Indolinonderivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
EP0235463A3 (en) * 1985-12-20 1990-01-17 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents
DE3600390A1 (de) * 1986-01-09 1987-07-16 Hoechst Ag Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
EP0290958A3 (de) 1990-08-08
DE3715763A1 (de) 1988-11-24
US4933346A (en) 1990-06-12
KR880013893A (ko) 1988-12-22
NO882065L (no) 1988-11-14
NO882065D0 (no) 1988-05-11
CN88102650A (zh) 1988-12-14
FI882177A (fi) 1988-11-13
ZA883342B (en) 1988-11-16
AU1605588A (en) 1988-11-17
DK259088D0 (da) 1988-05-11
JPS63297358A (ja) 1988-12-05
FI882177A0 (fi) 1988-05-10
HUT46897A (en) 1988-12-28
DK259088A (da) 1988-11-13
EP0290958A2 (de) 1988-11-17
IL86361A0 (en) 1988-11-15
PT87456B (pt) 1992-09-30

Similar Documents

Publication Publication Date Title
PT84078A (de) Dyarylalkyl-substituierte alkylamine verfahren zu ihrer herstellung ihre verwendung sowie sie enthaltende arzneimittel
PT76193A (de) Fibrinogenzubereitung verfahren zu ihrer herstellung und ihre verwendung
PT83013A (de) Tertiaere hydroxyalkylxanthine verfahren zu ihrer herstellung die sie enthaltende arzneimittel und ihre verwendung
DE69210067D1 (de) Hydraxamsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19475025I2 (de) Dialkoxypyridine, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel.
ATA191889A (de) Fettsäurezusammensetzung, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung, die sie enthält
DE59208394D1 (de) Diallylammonium-Verbindungen, Verfahren zu ihrer Herstellung sowie ihre Verwendung
PT78757B (de) Tetrahydropyridazinonderivate verfahren zu ihrer herstellung und ihre verwendung
PT74481A (de) Substituierte n-(4-indolyl-piperidino-alkyl)-benzimidazolone verfahren zu ihrer herstellung und ihre verwendung als pharma- zeutika
PT84460A (de) 1,1-disubstituierte cyclopropanderivate verfahren zu ihrer herstellung und ihre verwendung
PT69493A (de) Oximino-triazolyl-athane verfahren zu ihrer herstellung sowie ihre verwendung als fungizide
PT85302A (de) 7-acyloxy-6-aminoacyloxypolyxylabdane verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
PT87195A (pt) Neue 2-acylpyrrolidin-derivate verfahren zu ihrer herstellung sie enthaltende mittel sowie deren verwendung
PT86691A (pt) Alkylsubstituierte n-benzopyranyllactame verfahren zu ihrer herstellung ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
PT87660A (pt) Neue polyoxygenierte labdanderivate ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
PT86826A (pt) Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
PT87456A (pt) Diarylalkyl-substituierte alkylamine verfahren zu ihrer herstellung ihre verwendung sowie sie enthaltende arzneimittel
DE3887628D1 (de) Polymere Hydridosilazane und Verfahren zu ihrer Herstellung sowie ihre Verwendung.
PT74129B (de) 3,4-bis-substituierte 1,2,5-oxdiazol-2-oxide verfahren zu ihrer herstellung ihre verwendung und sie enthaltende pharmazeutische zubereitungen
DE59101569D1 (de) Arylsulfidverbindungen sowie Verfahren zu ihrer Herstellung.
PT88516A (pt) Neue aminosaereester verfahren zu ihrer herstellung sie enthaltende arzneimittel und deren verwendung
PT80906A (de) Substituierte guanidinobenzoesaeurephenylester verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
PT70934A (de) Substituierte n-allyl-acetanilide verfahren zu ihrer herstellung sowie ihre verwendung als fungizide
DE59108884D1 (de) Triphendioxazinverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
PT86748A (pt) Annelierte azepinon- und azocinon-derivat verfahren zu ihrer herstellung diese enthaltende mittel und ihre verwendung sowie zwischenprodukte bei ihrer herstellung

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920310

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19930930